Pubblicazioni

Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study

2021 - ENDOCRINE
Cipriani, C.; Piemonte, S.; Colangelo, L.; De Martino, V.; Diacinti, D.; Ferrone, F.; Piazzolla, V.; Fassino, V.; Nieddu, L.; Minisola, S.; Pepe, J.

Efficacy of denosumab therapy following treatment with bisphosphonates in women with osteoporosis: A cohort study

2021 - INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
Marocco, C.; Zimatore, G.; Mocini, E.; Fornari, R.; Iolascon, G.; Gallotta, M. C.; Bimonte, V. M.; Baldari, C.; Lenzi, A.; Migliaccio, S.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma